Erschienen in:
06.11.2021 | Original Article
Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure
verfasst von:
Fumitoshi Hirokawa, Masaki Ueno, Takuya Nakai, Masaki Kaibori, Takeo Nomi, Hiroya Iida, Shogo Tanaka, Koji Komeda, Shinya Hayami, Hisashi Kosaka, Daisuke Hokuto, Shoji Kubo, Kazuhisa Uchiyama
Erschienen in:
Langenbeck's Archives of Surgery
|
Ausgabe 2/2022
Einloggen, um Zugang zu erhalten
Abstract
Purpose
The efficacy of pre or postoperative chemotherapy for resectable colorectal cancer liver metastases (CRLM) is disputed. This study aimed to examine the risk factors for time to surgical failure (TSF) and analyze the efficacy of pre or postoperative chemotherapy prior to liver resection for CRLM.
Methods
The clinicopathological factors of 567 patients who underwent initial hepatectomy for CRLM at 7 university hospitals between April 2007 and March 2013 were retrospectively analyzed. The prognostic factors were identified and then stratified into two groups according to the number of preoperative prognostic factors: the high-score group (H-group, score 2–4) and the low-score group (L-group, score 0 or 1).
Results
Patients who experienced unresectable recurrence within 12 months after initial treatment had a significantly shorter prognosis than other patients (p < 0.001). Multivariate analysis identified age ≥ 70 (p = 0.001), pT4 (p = 0.015), pN1 (p < 0.001), carbohydrate antigen 19–9 ≥ 37 U/ml (p = 0.002), Clavien-Dindo grade ≥ IIIa (p = 0.013), and postoperative chemotherapy (p = 0.006) as independent prognostic factors. In the H-group, patients who received chemotherapy had a better prognosis than those who did not (p = 0.001).
Conclusion
Postoperative chemotherapy is beneficial in colorectal cancer patients with more than two of the following factors: age ≥ 70, carbohydrate antigen 19–9–positivity, pT4, and lymph node metastasis.